Christos Mantzoros, MD
Enriched profileProfessor of Medicine at Harvard Medical School; Chief of Endocrinology, Diabetes and Metabolism at Boston VA Healthcare System; Director of Human Nutrition at Beth Israel Deaconess Medical Center · Harvard Medical School
Christos Mantzoros is Professor of Medicine at Harvard Medical School; Chief of Endocrinology, Diabetes and Metabolism at Boston VA Healthcare System; Director of Human Nutrition at Beth Israel Deaconess Medical Center at Harvard Medical School. OpenAlex indexes 1,130 publications with 85,523 citations (h-index 149); ClinicalTrials.gov lists 16 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Christos Mantzoros, MD, is Professor of Medicine at Harvard Medical School. The public record shows 1,130 publications with 85,523 citations (h-index 149), centered on Adipokines, Inflammation, and Metabolic Diseases, Regulation of Appetite and Obesity, Diabetes, Cardiovascular Risks, and Lipoproteins. It also documents an investigator role on 16 registered clinical trials, industry payments reported by 13 companies, 8 NIH-funded awards (1997–2020).
- Most recent indexed publication: 2026 · Endocrine reviews
- Top research focus: Adipokines, Inflammation, and Metabolic Diseases
- 16 registered trials on ClinicalTrials.gov
- Open Payments reporting from 13 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 42 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 696.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mfa.gr ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 16 registered studies on ClinicalTrials.gov. The most recent:
- Improvement of Insulin Resistance After Bariatric Surgery
Sponsor: Beth Israel Deaconess Medical Center
- Activation of Brain Centers by Short-term Walnut Consumption in Obesity
Sponsor: Beth Israel Deaconess Medical Center
- Lorcaserin in Obesity: Identification of CNS Targets Using fMRI
Sponsor: Beth Israel Deaconess Medical Center
Industry payments
Updated 18 Oct 2026
13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202534 payments$38,741openpaymentsdata.cms.gov ↗
- Novo Nordisk IncProgram year202510 payments$18,182openpaymentsdata.cms.gov ↗
- Regeneron Pharmaceuticals, Inc.Program year202518 payments$17,130openpaymentsdata.cms.gov ↗
NIH funding
Updated 18 Oct 2026
8 NIH research awards on record, funded 1997–2020 per NIH RePORTER. The latest:
Congress activity
Updated 18 Oct 2026
18 congress contributions (2007–2025) across AACE, ADA, ASCO, ENDO per OpenAlex. The most recent:
- 1620-P: GDF15 Correlates with Insulin Sensitivity But Not with Features of Metabolic Dysfunction–Associated Steatotic Liver Disease
ADA Scientific Sessions
ADA2025Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Newer and novel antidiabetic drug classes across the cardiovascular-kidney-metabolic continuum.
Endocrine reviews
Article2026 - Proteomic Profiling of Plasma to Uncover Novel Intervention Targets and Prognostic Biomarkers for Chronic Liver Diseases.
Diabetes, obesity & metabolism
Article2026
Most-cited works
by citation count (OpenAlex)- 01Role of leptin in the neuroendocrine response to fastingArticle3,121 citations1996
- 02Adverse metabolic and cardiovascular consequences of circadian misalignmentArticle2,345 citations2009
- 03Obesity and cancer risk: Emerging biological mechanisms and perspectivesArticle1,562 citations2018
- 04Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeuticsArticle1,214 citations2018
- 05
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/christos-mantzoros-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of Athens
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu ↗ - DSc
University of Athens
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu ↗ - MMS/MMSc
Harvard Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu ↗ - MSc
Harvard School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu ↗
Editorial & leadership roles
journal and society appointments- Editor-in-Chief
Metabolism: Clinical and Experimental
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bidmc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bidmc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bidmc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bidmc.org ↗
Secondary affiliations
appointments beyond the home institution- Adjunct Professor of Medicine
Boston University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →research.bidmc.org ↗ - Director of Human Nutrition Unit
Joslin Diabetes Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →research.bidmc.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
William Sauer, MD
Harvard Medical School
Aleksandar Videnovic, MD
Harvard Medical School
Aparna Parikh, MD
Harvard Medical School
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
Mount Sinai Hospital